share_log

IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript Summary

IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript Summary

大麻股(IMCC)2024年第二季度业绩会文本摘要
moomoo AI ·  08/14 13:57  · 电话会议

The following is a summary of the IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript:

以下是Im Cannabis Corp. (IMCC) Q2 2024业绩会议通话记录摘要:

Financial Performance:

金融业绩:

  • Reported Q2 2024 revenue increased by 11.7% year over year, amounting to $14.8 million, primarily due to the strong performance in the German market.

  • Gross profit for Q2 2024 was $0.8 million, a decrease of 75.6% year over year, adversely impacted by clearing old inventory and accruals for slow-moving stock totaling approximately $1.9 million.

  • Operating expenses decreased by 29% due to reductions in G&A and sales & marketing expenditures.

  • Non-IFRS adjusted EBITDA loss in Q2 2024 was $2.3 million, a substantial increase from a loss of $0.5 million in Q2 2023.

  • Net loss slightly improved to $3.5 million in Q2 2024 from $3.7 million in Q2 2023.

  • 报告显示,Q2 2024年营业收入同比增长11.7%,达到1480万美元,主要由于德国市场表现强劲。

  • Q2 2024年毛利润为80万美元,同比下降75.6%,受旧库存清货和缓慢进货而影响,合计约190万美元。

  • 由于总务及销售市场支出减少,营业费用下降了29%。

  • Q2 2024年非IFRS调整后的EBITDA亏损为230万美元,较Q2 2023年的亏损500000美元大幅增加。

  • Q2 2024年净亏损略有改善,从Q2 2023年的370万美元降至350万美元。

Business Progress:

业务进展:

  • Focused on the German market post-cannabis legalization, resulting in Q2 sales climbing 200% compared to Q1.

  • Enhanced sales efforts in Germany led by establishing a supply chain from Israel to Germany and concentrating on reliably supplying mid-market to premium cannabis products.

  • Strengthened the premium product line in the Israeli market by launching and rebranding under BLKMKT, PICO, and IMC Craft brands.

  • 在大麻合法化后,重点关注德国市场,导致Q2销售额较Q1增长了200%。

  • 通过建立以色列到德国的供应链并专注于可靠地供应中档到高档的大麻产品,增强了在德国的销售力度。

  • 通过推出和重新推广BLKMKt,PICO和IMC Craft品牌,加强了以色列市场的高档产品线。

Opportunities:

机会:

  • The legalization of cannabis in Germany and subsequent market growth provide significant expansion opportunities, with expected growth from a $1.5 billion industry in 2024 to $3.7 billion by 2027.

  • Targeting an increase in the supply of premium and ultra-premium products in both the Israeli and German markets.

  • 德国大麻的合法化和随后的市场增长提供了重要的扩张机会,预计2024年1500万美元的行业板块在2027年将增长到3700万美元。

  • 在以色列和德国市场都力求增加高档和超高档产品的供应。

Risks:

风险:

  • Continued clearing of old inventory and accruing for slow-moving stock impacting the gross margin.

  • Reallocation of company resources prioritizing the German market poses potential risks if the expected returns are not met.

  • 继续清理旧库存和计提缓慢进货的股票会影响毛利率。

  • 公司资源的重新分配将优先考虑德国市场,如果预期的回报未达到,可能会带来潜在的风险。

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:本文由AI生成。文章内容的准确性无法完全保证。有关更全面的详细信息,请参阅IR网站。本文只是为投资者提供参考,没有任何指导或推荐建议。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发